×
About 580 results

ALLMedicine™ Clostridium Difficile Colitis Center

Research & Reviews  157 results

PediCRaFT: Pediatric Crohn's Disease Fecal Transplant Trial
https://clinicaltrials.gov/ct2/show/NCT03378167

Apr 29th, 2022 - Several recent studies have assessed the role of fecal microbiota transplantation (FMT) in the treatment of inflammatory bowel disease (IBD). IBD is a chronic autoimmune gastrointestinal disorder that has been associated with disease-specific micr...

Delayed Diagnosis of Clostridium difficile Colitis in a 48-Year-Old Woman with a Homozy...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895255
The American Journal of Case Reports; Caramoci A, Grigorescu A et. al.

Mar 1st, 2022 - BACKGROUND There are many causes of chronic colitis and diarrhea, including the effects of chemotherapy. Mutations in the UGT1A1 gene can be associated with increased toxicity from irinotecan-based chemotherapy. This report is of a case of delayed...

Persistent Clostridium difficile Colitis Mimicking A Fatal Case Of Strongyloides Hyperi...
https://doi.org/10.1016/j.ijid.2022.02.023
International Journal of Infectious Diseases : IJID : Off... Grossman J, Fan J et. al.

Feb 20th, 2022 - Strongyloidiasis, a disease caused by the helminth Strongyloides stercoralis, has been identified as a life-threatening parasitic infection among immunocompromised patients. In the most severe cases, which include hyperinfection syndrome and disse...

Outcomes of total versus partial colectomy in fulminant Clostridium difficile colitis: ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842562
World Journal of Emergency Surgery : WJES; Ahmed N, Kuo YH

Feb 15th, 2022 - The Total Abdominal Colectomy (TAC) is the recommended procedure for Fulminant Clostridium Difficile Colitis (FCDC), however, occasionally, FCDC is also treated with partial colectomies. The purpose of the study was to identify the outcomes of par...

Severe Acute Systemic Reaction After the First Injections of Ixekizumab
https://www.mdedge.com/dermatology/article/251368/psoriatic-arthritis/severe-acute-systemic-reaction-after-first-injections
John Pappas, MD, Maryam Liaqat, MD et. al.

Feb 2nd, 2022 - Case Report A 39-year-old woman who was otherwise healthy presented with fatigue, malaise, a resolving rash, focal lymphadenopathy, increasing distal arthritis, dactylitis, resolving ecchymoses, and acute onycholysis of 1 week’s duration that deve.

see more →

Drugs  1 results see all →

Clinicaltrials.gov  23 results

PediCRaFT: Pediatric Crohn's Disease Fecal Transplant Trial
https://clinicaltrials.gov/ct2/show/NCT03378167

Apr 29th, 2022 - Several recent studies have assessed the role of fecal microbiota transplantation (FMT) in the treatment of inflammatory bowel disease (IBD). IBD is a chronic autoimmune gastrointestinal disorder that has been associated with disease-specific micr...

Outcomes and Data Collection for Fecal Microbiota Transplantation for the Treatment of Recurrent Clostridium Difficile
https://clinicaltrials.gov/ct2/show/NCT03562741

Oct 5th, 2021 - Fecal microbiota transplantation (FMT) involves administering fecal material from a healthy individual into the gastrointestinal tract of the patient. This has been done in the past for recurrent colitis secondary to Clostridium difficile infectio...

Stool Transplants to Treat Refractory Clostridium Difficile Colitis
https://clinicaltrials.gov/ct2/show/NCT02127398

Sep 20th, 2021 - Recurrent colitis due to Clostridium difficile results from disruption of the normal gut flora, and is very difficult to treat. It is now clear that restoration of the normal gut flora is the most effective way to treat recurrent C. difficile coli...

Oral Vancomycin for Preventing Clostridium Difficile Recurrence
https://clinicaltrials.gov/ct2/show/NCT03200093

Apr 26th, 2021 - Clostridium difficile colitis is a significant cause of morbidity and mortality among hospitalized patients. Following the first episode, up to 15% of people experience recurrent disease. A major risk factor for recurrent disease is exposure to sy...

Microbiome of the Ageing Gut and Its Effect on Human Gut Health and Cognition.
https://clinicaltrials.gov/ct2/show/NCT04199195

Mar 15th, 2021 - Humans have co-evolved with populations of colonising microbes and their genomes to establish a mutually beneficial relationship. The gut microbiome represents the largest population of resident microbes in humans and is highly diverse and plays e...

see more →

News  51 results

Severe Acute Systemic Reaction After the First Injections of Ixekizumab
https://www.mdedge.com/dermatology/article/251368/psoriatic-arthritis/severe-acute-systemic-reaction-after-first-injections
John Pappas, MD, Maryam Liaqat, MD et. al.

Feb 2nd, 2022 - Case Report A 39-year-old woman who was otherwise healthy presented with fatigue, malaise, a resolving rash, focal lymphadenopathy, increasing distal arthritis, dactylitis, resolving ecchymoses, and acute onycholysis of 1 week’s duration that deve.

CD19 CAR T-Cell Therapy Shows Efficacy in Real-World Setting
https://www.onclive.com/view/cd19-car-tcell-therapy-shows-efficacy-in-realworld-setting

Oct 6th, 2021 - Amit K. Verma, MD Director of Hemato-Oncology, Montefiore Einstein Center for Cancer Care, Professor in the Department of Medicine, Department of Developmental and Molecular Biology, Albert Einstein College of Medicine Axicabtagene cilol...

Stopping IL-17 Drug for Axial Spondyloarthritis? Expect Spinal Flares
https://www.medpagetoday.com/rheumatology/backpain/92524

May 11th, 2021 - Among patients with axial spondyloarthritis who achieved remission during treatment with ixekizumab (Taltz), those who continued on treatment were less likely to flare than were those who withdrew from treatment, a randomized trial found. At week ...

Case Series Shows Feasibility of Haploidentical Transplant in High-Risk Myelofibrosis
https://www.onclive.com/view/case-series-shows-feasibility-of-haploidentical-transplant-in-highrisk-myelofibrosis

Dec 4th, 2020 - Keri Maher, DO, MS Haploidentical allogeneic stem cell transplant is a viable treatment option for patients with myelofibrosis who have a higher risk for posttransplant complications and mortality, according to a 3-patient case series shared in a...

Shorter Treatment Succeeds in Septic Arthritis
https://www.medpagetoday.com/rheumatology/arthritis/79351

Apr 22nd, 2019 - Two weeks of antibiotic therapy was as effective as 4 weeks for septic arthritis, a prospective single-center study found. Among 77 patients randomized to a 4-week course of therapy following surgical drainage for native joint bacterial arthritis,...

see more →